Document is current
Any future updates will be listed below
-
Authors
Hitz, F.
Kraus, M.
Pabst, T.
Hess, D.
Besse, L.
Silzle, T.
Novak, U.
Seipel, K.
Rondeau, S.
Stüdeli, S.
Vilei, S. Berardi
Samaras, P.
Mey, U.
Driessen, C.
,
- License Information
-
More Information
Article History
Received: 26 January 2019
Revised: 20 May 2019
Accepted: 28 May 2019
First Online: 27 August 2019
Conflict of interest
: FH has received consultancy fees from Celgene. PS has received consultancy fees or honoraria from Celgene, Takeda, Amgen, Novartis, and Janssen. UM has received consultancy fees, research funding, honoraria from Celgene, as well as honoraria for membership on an entity’s Board of Directors or advisory committees from Celgene.
